You searched for "screening"
The natural history of treatment naïve choroidal neovascularisation (CNV) in geographic atrophy
The aim of this retrospective study is to assess the characteristics and natural history of quiescent CNV in geographic atrophy (GA) utilising multi-modal imaging. Case notes were reviewed of patients diagnosed with geographic atrophy between January 2010 and December 2016...
Sex hormones in males and females with central serous chorioretinopathy
This study was aimed to assess the role of sex hormones in male and female patients with central serous chorioretinopathy (CSC), a disease with a pronounced male predilection. Two hundred and six patients, 183 males (mean age 52, median 52,...Her Royal Highness The Duchess of Edinburgh awarded Honorary Fellowship of The College of Optometrists for her outstanding contribution to eye health
The College of Optometrists has presented Her Royal Highness The Duchess of Edinburgh with an Honorary Fellowship of the College in recognition of Her Royal Highness’s outstanding contribution to eye health. The Duchess is passionate about preventing avoidable sight loss...
Outcomes in intermediate age-related macular degeneration (AMD): A MACUSTAR study report
Intermediate AMD (iAMD) is the most high-risk AMD stage for progressing to late AMD. This article gives the report of the MACUSTAR study. A wide range of assessments were conducted across 20 sites in seven European countries, in accordance with...World Optometry Day 2022
Today, Wednesday 23rd March, is #WorldOptometryDay. A day to celebrate the global community of optometrists and all the eye care professionals that support the ophthalmic health and wellbeing of many millions of patients.The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE
The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....Orbis and Heidelberg Engineering announce expansion of collaboration during a special visit to the Flying Eye Hospital in Rwanda
The medtech imaging and data solutions company, Heidelberg Engineering, and sightsaving nonprofit, Orbis, have come together on board the Orbis Flying Eye Hospital during its latest programme in Kigali, Rwanda, to announce the expansion of their collaboration in making educational...
Clinicopathologic factors and survival in patients with sebaceous carcinoma of eyelid
This is a population-based analysis performed to evaluate the prognostic factors and survival of patients with sebaceous carcinoma of the eyelid. Patients with eyelid sebaceous carcinoma from 1973-2013 were identified from the Surveillance, Epidemiology and End Results (SEER) database and...
